Careers  |  Sign In  |  Register  |   Twitter

Latest in Oncology

Clark Chen, MD, PhD explains that the most common form of brain cancer, glioblastoma, is also one of the most deadly cancers. Despite efforts to find treatments and cures for the disease, the average survival of these patients is 14 months. However, new MRI-Guided gene therapy is a more precise method of...
USA Today reports that healthcare officials are raising concerns about the chemical bisphenol A (BPA), an estrogen-like compound, and its link to the development of breast cancer. BPA is often used in packaging because it "helps to extend a product's shelf life and protects food from contamination and...

Reuters Health • The Doctor's Channel Daily Newscast

Bevacizumab Added to Capecitabine Benefits Elderly with Metastatic CRC

NEW YORK (Reuters Health) – A multinational study has shown that progression-free survival in elderly patients with untreated metastatic colorectal cancer (CRC) is improved significantly when bevacizumab is added to capecitabine chemotherapy, and treatment is well tolerated. While overall survival was...